Effects of ACE inhibitor/ARB therapy and long COVID on kidney disease: a retrospective cohort study using real-world data.

Yue ZhangDjibril M BaKathryn RisherDuanping LiaoLeslie J ParentNasrollah GhahramaniVernon M Chinchilli

Published in: Clinical kidney journal (2024)

ACEI/ARB treatment does not increase the incidence of CKD or AKI, regardless of long COVID status. However, long COVID itself is associated with increasing risks of kidney diseases and all-cause mortality.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
acute kidney injury
chronic kidney disease
risk factors
electronic health record
machine learning
human health
big data
angiotensin converting enzyme
mesenchymal stem cells
data analysis
cell therapy